Meanwhile, miR-217 was reported to function as a tumor suppressor in HCC progression and miR-217/E2F3 and miR-214/E2F3 axises may be potential candidates for developing rational therapeutic approaches [51, 83]. The gene discussed is E2F3; the disease is hepatocellular carcinoma.